$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Alpha-1-Proteinaseninhibitor-Mangel
Alpha-1 proteinase inhibitor deficiency: diagnostic procedures, clinical manifestation and treatment : Diagnostik, Krankheitsverlauf und Therapieoptionen

Medizinische Klinik, v.94 no.7, 1999년, pp.371 - 376  

Köhnlein, Thomas ,  Klein, Helmut ,  Welte, Tobias

Abstract AI-Helper 아이콘AI-Helper

Alpha-1 antitrypsin (alpha-1 proteinase inhibitor) deficiency is characterized by a marked reduction of alpha-1 antitrypsin, the major antiprotease in man....

참고문헌 (51)

  1. Am J Respir Crit Care Med RK Albert 158 71 1998 10.1164/ajrccm.158.1.9705067 Albert RK, Benditt JO, Hildebrandt J, et al. Lung volume reduction surgery has variable effects on blood gases in Patients with emphysema. Am J Respir Crit Care Med 1998;158:71-6. 

    상세보기 crossref

  2. Am J Respir Crit Care Med American Thoracic Society 152 84 1995 10.1164/ajrccm/152.5_Pt_2.S84 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S84-106. 

    상세보기 crossref

  3. Ann Intern Med NR Anthonisen 106 196 1987 10.7326/0003-4819-106-2-196 Anthonisen NR, Manfreda J, Warren J. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. 

    상세보기 crossref

  4. Chest AF Barker 105 1406 1994 10.1378/chest.105.5.1406 Barker AF, Siemsen F, Pasley D, et al. Replacement therapy for hereditary alpha-1-antitrypsin deficiency. A program for long-term administration. Chest 1994;105:1406-10. 

    상세보기 crossref

  5. N Engl J Med A Boehler 335 1275 1996 10.1056/NEJM199610243351704 Boehler A, Speich R, Russi EW, et al. Lung Transplantation for Llymphangioleiomyomatosis. N Engl J Med 1996;335:1275-80. 

    상세보기 crossref

  6. Thorax J Bourbeau 53 477 1998 10.1136/thx.53.6.477 Bourbeau J, Rouleau MY, Boucher S. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax 1998;53:477-82. 

    상세보기 crossref

  7. Am Rev Respir Dis ML Brantly 138 327 1988 10.1164/ajrccm/138.2.327 Brantly ML, Lester DP, Miller BH, et al. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988;138:327-36. 

    상세보기 crossref

  8. Am J Med M Brantly 84 Suppl 6A 13 1988 10.1016/0002-9343(88)90154-4 Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1 Anitrtypsin deficiency. Am J Med 1988;84:Suppl 6A:13-31. 

    상세보기 crossref

  9. Dtsch Med Wochenschr J Braun 115 889 1990 10.1055/s-2008-1065095 Braun J, Welle S, van Wees J, et al. Dauersubstitution bei homozygotem Alpha1-Antitrypsin-Mangel. Dtsch Med Wochenschr 1990;115:889-94. 

    상세보기 crossref

  10. Eur Respir J PC Cassina 12 1028 1998 10.1183/09031936.98.12051028 Cassina PC, Teschler H, Konietzko N, et al. Two-year results after lung volume reduction surgery in alpha1-antitrypsin deficiency versus smoker’s emphysema. Eur Respir J 1998;12:1028-32. 

    상세보기 crossref

  11. J Thorac Cardiovasc Surg JD Cooper 109 106 1995 10.1016/S0022-5223(95)70426-4 Cooper JD, Trulock EP, Triantafillou AN. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109:106-19. 

    상세보기 crossref

  12. N Engl J Med S Eriksson 314 736 1986 10.1056/NEJM198603203141202 Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1 antitrypsin deficiency. N Engl J Med 1986;314:736-9. 

    상세보기 crossref

  13. J Clin Invest JE Gadek 68 889 1981 10.1172/JCI110344 Gadek JE, Fells GA, Zimmerman RL, et al. Antielastases of the human alveolar structures. J Clin Invest 1981; 68:889-98. 

    상세보기 crossref

  14. Science JE Gadek 206 1315 1979 10.1126/science.316188 Gadek JE, Fells GA, Crystal RG. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science 1979;206:1315-6. 

    상세보기 crossref

  15. Dtsch Ärztebl HJ Graf 89 2701 1992 Graf HJ, Konietzko N. Substitutionstherapie bei schwerem Alpha-1 Proteasen Inhibitor-Mangel und Lungenemphysem. Dtsch Ärztebl 1992;89:2701-3. 

  16. Chest RF Grossman 113 Suppl 249s 1998 10.1378/chest.113.4_Supplement.249S Grossman RF. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Chest 1998;113:Suppl:249s-55s. 

    상세보기 crossref

  17. Am J Publ Hlth JW Hay 81 427 1991 10.2105/AJPH.81.4.427 Hay JW, Robin ED. Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease. Am J Publ Hlth 1991;81:427-33. 

    상세보기 crossref

  18. Lancet JD Hosenpud 351 24 1998 10.1016/S0140-6736(97)06405-2 Hosenpud JD, Bennett LE, Keck BM, et al. for the Joint United Network for Organ Sharing/International Society for Heart and Lung Transplantation. Thoracic Registry, Richmond, VA, USA. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-7. 

    상세보기 crossref

  19. Ann Intern Med RC Hubbard 111 206 1989 10.7326/0003-4819-111-3-206 Hubbard RC, Brantly ML, Sellers SE, et al. Delivery of proteins for therapeutic purposes by aerosolisation: direct augmentation of anti-neutrophil esastase defences of the lower respiratory tract in alpha-1 antitrypsin deficiency with an aerosol of alpha-1 antitrypsin. Ann Intern Med 1989;111:206-12. 

    상세보기 crossref

  20. Eur Respir J DCS Hutchison 10 2191 1997 10.1183/09031936.97.10102191 Hutchison DCS, Hughes MD. Alpha-1 antitrypsin replacement therapy: will its efficacy ever be proved? Eur Respir J 1997;10:2191-3. 

    상세보기 crossref

  21. Thorax JW Jenne 49 97 1994 10.1136/thx.49.2.97 Jenne JW. What role for theophylline therapy? Thorax 1994;49:97-100. 

    상세보기 crossref

  22. Am J Respir Crit Care Med VM Keatings 155 542 1997 10.1164/ajrccm.155.2.9032192 Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997;155:542-8. 

    상세보기 crossref

  23. Köhnlein T, Piecyk A, Klein H, et al. Diagnostische Wertigkeit der Serumelektrophorese bei Alpha-1 Antitrypsin-Mangel. Pneumologie 1998:Sonderheft I:S66. 

  24. Intensivmedizin N Konietzko 32 261 1995 Konietzko N. Therapeutische Strategien bei Alpha-1 Proteaseninhibitormangel. Intensivmedizin 1995;32:261-5. 

  25. Atemw u Lungenkrh N Konietzko 17 593 1991 Konietzko N, Eberhard D, El Beheidy T. Lungenemphysem bei Alpha-1 PI-Mangel. Atemw u Lungenkrh 1991; 17:593-9. 

  26. 2 1996 Weißbuch Lunge. Defizite, Zukunftsperspektiven. Forschungsansätze Konietzko N, Fabel H, Hrsg. Weißbuch Lunge. Defizite, Zukunftsperspektiven. Forschungsansätze. Stuttgart: Thieme, 1996:2-6. 

  27. Lloyd CA, Arbtan KD. Rapid screening for human alpha1-proteinase inhibitor deficiency. Ann NY Acad Sci 1995:16-8. 

  28. Löfdahl CG, Pauwels R, Boe J, et al. EUROSCOPE. Randomisierte, kontrollierte Studie zum Effekt des inhalativen Glukokortikoids Budesonid auf den langfristigen Verlauf von FEV1 bei Patienten mit COPD. Vortrag auf dem Kongreß der European Respiratory Society, Berlin, 1997. 

  29. EC Lucey 2237 1997 The lung Lucey EC, Stone PJ, Snider GL. Consequences of proteolytic injury. In: Crystal RG, West JB, et al. The lung. Philadelphia: Scientific Foundations, 1997:2237-50. 

  30. Eur Respir Rev J Martinez 45 240 1997 Martinez J. Antibiotics and vaccination therapy in COPD. Eur Respir Rev 1997;45:240-2. 

    상세보기

  31. NG McElvaney 2205 1997 The lung McElvaney NG, Crystal RG. Proteases and lung injury. In: Crystal RG, West JB, et al. The lung. Philadelphia: Scientific Foundations, 1997:2205-18. 

  32. Ann Thorac Surg KS Naunheim 62 601 1996 10.1016/0003-4975(96)00428-6 Naunheim KS, Ferguson MK. The current status of lung volume reduction operations for emphysema. Ann Thorac Surg 1996;62:601-2. 

    상세보기 crossref

  33. Am J Respir Crit Care Med JA Noord van 157 A799 1998 van Noord JA, de Munck DRAJ, Bantje TA, et al. Efficacy and safety of Salmeterol (SLM) and Ipratropiumbromide (IPB) in patients with chornic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998;157:A799. 

  34. 10.1016/S0889-8553(21)00247-8 Perlmutter DH. Clinical manifestations of alpha1-antitrypsin deficiency. Gastroenterol Clin North Am, Pediat Gastroenterol Part II. 1995:27-43. 

    상세보기 crossref

  35. Am J Respir Crit Care Med N Seersholm 151 369 1995 10.1164/ajrccm.151.2.7842193 Seersholm N, Kok-Jensen A. Survival in relation to lung function and smoking cessation in patients with severe heredetary alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 1995;151:369-73. 

    상세보기 crossref

  36. Eur Respir J N Seersholm 10 2260 1997 10.1183/09031936.97.10102260 Seersholm N, Wencker M, Banik N, et al. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1 antitrypsin deficiency? Eur Respir J 1997;10:2260-3. 

    상세보기 crossref

  37. Eur Respir J NM Siafakas 8 1398 1995 10.1183/09031936.95.08081398 Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995;8:1398-420. 

    상세보기 crossref

  38. Acta Clin Belg W Steenbergen v. 48 171 1993 10.1080/17843286.1993.11718305 Steenbergen W v. Alpha-1 antitrypsin deficiency: An overview. Acta Clin Belg 1993;48:171-89. 

    상세보기 crossref

  39. Respiration PJ Stone 62 76 1995 10.1159/000196395 Stone PJ, Morris TA, Franzblau C, et al. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked clastin in alpha-1-antitrypsin deficient humans. Respiration 1995;62:76-9. 

    상세보기 crossref

  40. N Engl J Med T Sveger 294 1316 1976 10.1056/NEJM197606102942404 Sveger T. Liver disease in alpha-1 antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21. 

    상세보기 crossref

  41. Am J Respir Crit Care Med The Alpha-1-Antitrypsin Deficiency Registry Study Group 158 49 1998 10.1164/ajrccm.158.1.9712017 The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha-1-antritrypsin. Am J Respir Crit Care Med 1998;158:49-59. 

    상세보기 crossref

  42. Pneumologie C Vogelmeier 48 57 1994 Vogelmeier C, Buhl R. Therapie von Lungenkrankheiten mit Antiproteasen. Pneumologie 1994;48:57-62. 

    상세보기

  43. Am J Respir Crit Care Med C Vogelmeier 155 536 1997 10.1164/ajrccm.155.2.9032191 Vogelmeier C, Kirlath I, Warrington S, et al. The intrapulmonary half-life and safety of aerosolized alpha-1 protease inhibitor in normal volunteers. Am J Respir Crit Care Med 1997;155:536-41. 

    상세보기 crossref

  44. Eur Respir J M Wencker 11 428 1998 10.1183/09031936.98.11020428 Wencker M, Banik N, Buhl R, et al. Long-term treatment of Alpha-1 antitrypsin deficiency-related pulmonary emphysema with human alpha-1 antitrypsin. Eur Respir J 1998;11:428-33. 

    상세보기 crossref

  45. Atemw u Lungenkrh M Wencker 20 212 1994 Wencker M, Konietzko N. Prävention und Therapie des Lungenemphysems bei Alpha1-Protease-Inhibitor-Mangel. Atemw u Lungenkrh 1994;20:212-6. 

  46. Pneumologie T Welte 50 838 1996 Welte T. Proteinasen-/Antiproteinasengleichgewicht bei Patienten mit zystischer Firbrose. Pneumologie 1996;50:838-40. 

    상세보기

  47. Internist (Berlin) T Welte 39 152 1998 10.1007/s001080050153 Welte T. Akute Luftnot. Internist (Berlin) 1998;39:152-60. 

    상세보기 crossref

  48. R Wettengel 176 1995 Bronchitis Wettengel R. Therapie der Bronchitis. In: Konietzko N. Bronchitis. München: Urban & Schwarzenberg, 1995: 176-98. 

  49. N Engl J Med MD Wewers 316 1055 1987 10.1056/NEJM198704233161704 Wewers MD, Casolaro MA, Crystal RG. Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62. 

    상세보기 crossref

  50. Am Rev Respir Dis. MD Wewers 135 539 1987 Wewers MD, Casolaro MA, Crystal RG. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype nullnull before and during alpha-1-antitrypsin augmentation therapy. Am Rev Respir Dis. 1987;135:539-43. 

    상세보기

  51. Chest R Wilson 113 4 Suppl 242s 1998 10.1378/chest.113.4_Supplement.242S Wilson R. The role of infection in COPD. Chest 1998;113:4 Suppl:242s-8s. 

    상세보기 crossref

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로